Medikit Co.,Ltd.
JPX: 7749.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Hiroaki Nakajima
- Employees
- 966
- Headquarters
- Tokyo, Japan
- IPO year
- 2005
- Market cap
- ¥43.1B
- Website
- https://www.medikit.co.jp
Loading 7749…
Loading profile data…Frequently asked questions about 7749
What does Medikit Co.,Ltd. (7749.T) do?
Medikit Co.,Ltd. engages in the manufacture and sale of vascular access medical devices. The company offers IV catheters, such as Supercath 5, Supercath Z3V, and Supercath Ztu-V; hemodialysis products, including Supercath PRO, Supercath NEO, and Supercath Clampcath; and intervention products comprising Supersheath and Mongoose. Its products are...
Where does 7749.T trade?
Medikit Co.,Ltd. (7749.T) trades on the Tokyo Stock Exchange.
What sector is 7749.T in?
Medikit Co.,Ltd. (7749.T) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Medikit Co.,Ltd.?
Hiroaki Nakajima is the chief executive officer of Medikit Co.,Ltd. (7749.T).
Where is Medikit Co.,Ltd. headquartered?
Medikit Co.,Ltd. is headquartered in Japan.
Does 7749.T pay a dividend?
Yes — Medikit Co.,Ltd. (7749.T) paid a trailing twelve-month dividend of JPY 100.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 7749.T go public?
Medikit Co.,Ltd. (7749.T) completed its initial public offering in 2005.